Related Experiment Video
Updated: Aug 19, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Melatonin is neuroprotective in experimental Streptococcus pneumoniae meningitis
Joachim Gerber1, Miriam Lotz, Sandra Ebert
1Department of Neurology, Georg-August-University, Gottingen, Germany.
Abstract:
Neuronal injury in bacterial meningitis is a consequence of the direct toxicity of bacterial components and inflammatory and oxidative mechanisms. Adjunctive therapy with melatonin was investigated in vitro and in experimental meningitis. Cellular damage was reduced by treatment with melatonin in organotypic hippocampal cultures (P<.001) and in human SH-SY5Y cells (P<.01). Rabbits were infected intracisternally with Streptococcus pneumoniae and received either melatonin (20 mg/kg body weight/24 h; n=12) or saline (n = 11) intravenously. Twelve hours later, all rabbits received ceftriaxone (10 mg/kg body weight/h). The density of apoptotic dentate granule cells was lower in melatonin-treated rabbits (81.8+/-52.9 vs. 227.5+/-127.9 cells/mm(2); P=.002). The activity of superoxide dismutase in the hippocampal formation was higher (P=.04), and nitrite concentrations in cerebrospinal fluid were lower, after treatment with melatonin (P=.003). Melatonin reduced neuronal injury in vitro and in experimental meningitis, and it may be suitable as adjunctive therapy in human meningitis.
Insights
Melatonin significantly reduced neuronal injury in bacterial meningitis models. This antioxidant may be a valuable adjunctive therapy for human meningitis, improving outcomes by protecting brain cells.
Area of Science:
- Neuroscience
- Pharmacology
- Infectious Diseases
Background:
- Bacterial meningitis causes neuronal injury through direct toxicity, inflammation, and oxidative stress.
- Melatonin, an antioxidant, has been explored for neuroprotective effects.
Purpose of the Study:
- To investigate the efficacy of melatonin as an adjunctive therapy against neuronal injury in experimental bacterial meningitis.
Main Methods:
- In vitro studies using organotypic hippocampal cultures and human SH-SY5Y cells.
- In vivo study in rabbits infected with Streptococcus pneumoniae, treated with melatonin and ceftriaxone.
Main Results:
- Melatonin reduced cellular damage in vitro (P<.001, P<.01).
- In vivo, melatonin decreased apoptotic dentate granule cells (P=.002) and cerebrospinal fluid nitrite (P=.003), while increasing superoxide dismutase activity (P=.04).
Conclusions:
- Melatonin demonstrates neuroprotective effects in experimental bacterial meningitis.
- Melatonin shows potential as an adjunctive therapy to reduce neuronal injury in human meningitis.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Bacterial Meningitis I: Introduction
Bacterial Meningitis
Cryptococcal Meningitis

